| Entry |
|
|---|
| Name |
Cipralisant maleate (USAN);
Perceptin (TN) |
|---|
| Formula |
C14H20N2. C4H4O4
|
|---|
| Exact mass |
332.1736
|
|---|
| Mol weight |
332.39
|
|---|
| Structure |
|
|---|
| Class |
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01556 Histamine receptor H3 antagonist
|
|---|
| Efficacy |
Nootropic, H3 receptor antagonist |
|---|
| Comment |
Treatment of attention deficit hyperactive disorders (ADHD), age related memory dysfunction, and other cognitive disorders
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01556 Histamine receptor H3 antagonist
D03518 Cipralisant maleate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH3
D03518 Cipralisant maleate (USAN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 24
1 C1y C 11.3250 -15.1551
2 C1y C 12.7279 -15.1551
3 C1x C 12.0264 -13.9627
4 C3b C 13.9202 -15.8565
5 C8y C 10.0626 -15.8565
6 C8x C 10.0592 -17.2680
7 N5x N 8.7609 -17.6795
8 C8x C 7.9446 -16.5626
9 N4x N 8.7476 -15.4252
10 C3b C 15.1127 -16.5579
11 C1b C 16.3274 -17.2593
12 C1b C 17.5254 -16.5675
13 C1d C 18.7151 -17.2544
14 C1a C 19.9300 -17.9558
15 C1a C 19.4165 -16.0395
16 C1a C 18.0137 -18.4692
17 C2b C 25.7038 -15.2954
18 C2b C 27.3170 -15.2954
19 C6a C 25.0024 -16.4877
20 C6a C 28.0184 -16.4877
21 O6a O 29.4212 -16.4877
22 O6a O 23.5996 -16.4877
23 O6a O 25.7038 -17.6802
24 O6a O 27.3872 -17.6802
BOND 24
1 1 2 1
2 2 3 1
3 1 3 1
4 2 4 1 #Up
5 1 5 1 #Down
6 5 6 2
7 6 7 1
8 7 8 2
9 8 9 1
10 5 9 1
11 4 10 3
12 10 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 13 15 1
17 13 16 1
18 17 18 2
19 17 19 1
20 18 20 1
21 20 21 2
22 19 22 1
23 19 23 2
24 20 24 1
|
|---|
